These peptide growth factors, which are extracellular ligands, induce transcriptional activation of a concensus estrogen response element (ERE) in an ER-dependent manner in various cell types, including breast cancer and ovarian cancer cell lines. The gene discussed is ESR1; the disease is ovarian carcinoma.